AVTX- Avalo Therapeutics, Inc.

Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.

Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Neil Garry Arthur	190.3K	-	-
Other	Boyd Taylor	95.0K	-	-
Other	Doyle Mittie	51.8K	$1.04M	-
CFO	Sullivan Christopher Ryan	39.9K	$651.7K	-
Other	Riley Jennifer	37.0K	$725.6K	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 9, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	14,426	$3.91	$56,439.70	+1.0%	-97.6%	-98.9%
May 31, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	844	$2.87	$2,422.28	-	-96.6%	-98.3%
May 30, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	2,671	$2.79	$7,463.76	+0.2%	-96.5%	-98.2%
May 24, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	9,000	$2.98	$26,816.45	+0.7%	-96.9%	-98.4%
May 22, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	26,621	$3.36	$89,372.49	+2.0%	-96.3%	-98.5%
May 16, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	4,379	$2.51	$11,006.72	+0.3%	-95.3%	-98.4%
May 8, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	25,000	$2.77	$69,364.50	+1.9%	-93.9%	-97.9%
Apr 27, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	7,500	$2.99	$22,423.19	+0.6%	-91.8%	-97.6%
Apr 24, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	17,500	$3.07	$53,671.50	+1.4%	-91.8%	-98.2%
Apr 18, 2023	Caissa Capital Management Ltd.	10% Owner	Buy	25,000	$2.95	$73,874.00	+2.0%	-87.8%	-98.0%